Efficacy assessment of cell therapy with autologous fibroblast in skin aging
Phase 1
- Conditions
- Face wrinkles.Other specified disorders of skin and subcutaneous tissue
- Registration Number
- IRCT201506271159N17
- Lead Sponsor
- Skin and Stem Cell Research Center, Maryam aley, South kamraneye, Tehran, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
age about 35 to 55 years old;- Patients with mild to moderate wrinkles according to Glogue scale I-III; No coagulation disorders and use of anti coagulated drugs; No infection in treated site; No fever able diseases; No chronic liver diseases; No pregnancy or breast-feeding; Having no anatomic disorder in face; Normal mental health; Having a good cooperation with research team.
Exclusion Criteria
being smokers or drinkers; any past skin intervention in face; Having many wrinkles on the face; type of 1 or 5 of wrinkle scoring; having a mental disorder; having an obsessed disorder; having any skin disorder; having any major disorder; having a systemic disorder; having an oral disorder;
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of face wrinkles. Timepoint: 1- 3 - 6 Month after cell therapy. Method of measurement: Biometry with visioface & skin sonography.
- Secondary Outcome Measures
Name Time Method